COMMERCIAL

Drug delivery via an active patch, rather than injection, has a lower total cost of administration, a wider potential audience, higher patient acceptance and lower regulatory barriers. The programmable active patch also opens up market potential for both new treatments with existing and new drugs, and new treatments employing mature drugs. Molecular size is no impediment to this technology and many mature drugs and compounds are immediate candidates for application.

PATIENT

Patients will prefer this method of drug administration and clinicians and medical administrators will also find significant advantages. OBJ's Active patch can deliver a complete patient and programming management solution in a low cost drug patch. Individual patches are microprocessor controlled for secure tamper-proof delivery and are equipped with full patient and time data logging capabilities. This specifically allows for individual electronic prescriptions on a patch for outpatients and homecare applications.

COMPLIANCE

OBJ's Active patch provides managed delivery on an OTC or outpatient basis. It can deliver continuous ultra-low dosages while allowing patient override and therapy on demand, all against auditable prescriptions.

It should be noted that the OBJ active drug patch acts independent of the target drug, and as a result is regulated as a Class IIA medical device.